Crewe Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.5K | Buy |
726
+142
| +24% | +$15.7K | 0.01% | 244 |
|
|
2025
Q1 | $65.4K | Sell |
584
-531
| -48% | -$59.5K | 0.01% | 246 |
|
|
2024
Q4 | $103K | Sell |
1,115
-560
| -33% | -$51.7K | 0.01% | 204 |
|
|
2024
Q3 | $140K | Buy |
1,675
+5
| +0.3% | +$419 | 0.02% | 187 |
|
|
2024
Q2 | $115K | Sell |
1,670
-254
| -13% | -$17.4K | 0.01% | 248 |
|
|
2024
Q1 | $141K | Buy |
+1,924
| New | +$141K | 0.02% | 225 |
|
|
2023
Q3 | – | Sell |
-1,133
| Closed | -$87.3K | – | 713 |
|
|
2023
Q2 | $87.3K | Sell |
1,133
-85
| -7% | -$6.55K | 0.01% | 214 |
|
|
2023
Q1 | $101K | Sell |
1,218
-130
| -10% | -$10.8K | 0.01% | 229 |
|
|
2022
Q4 | $116K | Sell |
1,348
-352
| -21% | -$30.2K | 0.02% | 204 |
|
|
2022
Q3 | $105K | Buy |
1,700
+677
| +66% | +$41.8K | 0.02% | 220 |
|
|
2022
Q2 | $63K | Buy |
1,023
+73
| +8% | +$4.5K | 0.01% | 266 |
|
|
2022
Q1 | $56K | Sell |
950
-6
| -0.6% | -$354 | 0.01% | 220 |
|
|
2021
Q4 | $69K | Buy |
+956
| New | +$69K | 0.01% | 163 |
|
|
2020
Q4 | – | Sell |
-60
| Closed | -$4K | – | 538 |
|
|
2020
Q3 | $4K | Buy |
+60
| New | +$4K | ﹤0.01% | 395 |
|
|
2019
Q4 | – | Sell |
-417
| Closed | -$26K | – | 259 |
|
|
2019
Q3 | $26K | Hold |
417
| – | – | 0.01% | 150 |
|
|
2019
Q2 | $28K | Hold |
417
| – | – | 0.01% | 170 |
|
|
2019
Q1 | $27K | Hold |
417
| – | – | 0.01% | 146 |
|
|
2018
Q4 | $26K | Sell |
417
-400
| -49% | -$24.9K | 0.01% | 149 |
|
|
2018
Q3 | $63K | Hold |
817
| – | – | 0.05% | 103 |
|
|
2018
Q2 | $58K | Hold |
817
| – | – | 0.05% | 111 |
|
|
2018
Q1 | $62K | Hold |
817
| – | – | 0.06% | 98 |
|
|
2017
Q4 | $59K | Buy |
+817
| New | +$59K | 0.06% | 106 |
|